Synchronous colorectal liver metastases:therapeutic considerations

作     者：Michael R.Driedger Sean P.Cleary David M.Nagorney 

作者机构：Division of Hepatobiliary and Pancreatic SurgeryAtrium HealthCharlotteNCUSA Division of Hepatobiliary and Pancreatic SurgeryMayo ClinicRochesterMNUSA 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2021年第10卷第5期

页      面：711-713页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：colorectal metastases patients 

摘      要：More than 50%of patients will develop colorectal cancer(CRC)liver metastases(CRCLM)during the course of their disease,while 15-25%of patients will have metastatic disease present at the time of initial diagnosis.Resection of CRCLM is possible in approximately one-in-four patients and 5-year overall survival(OS)rates have improved to nearly 60%in selected patients who undergo resection.